334 related articles for article (PubMed ID: 26991993)
1. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
[TBL] [Abstract][Full Text] [Related]
2. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
[TBL] [Abstract][Full Text] [Related]
3. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
4. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
Saw CL; Hannach B; Petrazsko T; Nickerson P
Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of leucocyte alloantibodies in blood donors from South China.
Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
[TBL] [Abstract][Full Text] [Related]
6. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
7. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
8. Are we underestimating reverse TRALI?
De Clippel D; Emonds MP; Compernolle V
Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
[TBL] [Abstract][Full Text] [Related]
9. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
[TBL] [Abstract][Full Text] [Related]
10. Identification of specificities of antibodies against human leukocyte antigens in blood donors.
Endres RO; Kleinman SH; Carrick DM; Steele WR; Wright DJ; Norris PJ; Triulzi D; Kakaiya R; Busch MP;
Transfusion; 2010 Aug; 50(8):1749-60. PubMed ID: 20158682
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
[TBL] [Abstract][Full Text] [Related]
12. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
13. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
Jug R; Anani W; Callum J
Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
[TBL] [Abstract][Full Text] [Related]
14. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.
Triulzi DJ; Kleinman S; Kakaiya RM; Busch MP; Norris PJ; Steele WR; Glynn SA; Hillyer CD; Carey P; Gottschall JL; Murphy EL; Rios JA; Ness PM; Wright DJ; Carrick D; Schreiber GB
Transfusion; 2009 Sep; 49(9):1825-35. PubMed ID: 19453983
[TBL] [Abstract][Full Text] [Related]
15. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
16. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.
Peters AL; Van Stein D; Vlaar AP
Br J Haematol; 2015 Sep; 170(5):597-614. PubMed ID: 25921271
[TBL] [Abstract][Full Text] [Related]
18. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
[TBL] [Abstract][Full Text] [Related]
19. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.
Muro M; Rivera J; Botella C; Campillo JA; Ferrer F; Alvarez-López MR
Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]